FDA — authorised 29 December 1951
- Marketing authorisation holder: BAXTER HLTHCARE CORP
- Status: approved
FDA authorised Vialin on 29 December 1951
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 29 December 1951.
BAXTER HLTHCARE CORP holds the US marketing authorisation.